Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy vectors and cytosine deaminases

Gene therapy vectors and cytosine deaminases

US Patent 10035983 · Granted Jul 31, 2018

Estimated economic value: $2,225,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Co-production of hydrogen, carbon, and electricity with carbon dioxide capture2024
Recombinant vectors comprising 2A peptide2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Formulations of 5-fluorocytosine and uses thereof2021
Formulations of 5-fluorocytosine and uses thereof2021
Retroviral vector with mini-promoter cassette2021
Retroviral vector with mini-promoter cassette2021
Retroviral vector with mini-promoter cassette2021
Vectors and methods for long-term immune evasion to prolong transplant viability2021
Producer cells for replication competent retroviral vectors2021
Formulations of 5-fluorocytosine and uses thereof2019